How have YECO shares performed in 2024?

EV Biologics' stock was trading at $1.00 at the beginning of 2024. Since then, YECO stock has decreased by 39.8% and is now trading at $0.6021. View the best growth stocks for 2024 here .

Are investors shorting EV Biologics?

EV Biologics saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 100 shares, a decrease of 75.0% from the February 29th total of 400 shares. Based on an average daily trading volume, of 400 shares, the short-interest ratio is currently 0.3 days. View EV Biologics' Short Interest .

How do I buy shares of EV Biologics?

Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:YECO

EV Biologics (YECO) Stock Price, News & Analysis

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)

Free YECO Stock Alerts

$0.60

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.60
▼
$0.60
50-Day Range: $0.56
▼
$0.99
52-Week Range: $0.56
▼
$1.95

Volume: 1 shs
Average Volume: 467 shs
Market Capitalization: $6.16 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get EV Biologics alerts:

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About EV Biologics Stock (OTCMKTS:YECO)

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

YECO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

YECO Stock News Headlines

March 22, 2024 | morningstar.com

NurExone Biologic Inc NRXBF

February 21, 2024 | usatoday.com

Best EV stocks in February 2024

April 19, 2024 | Crypto Swap Profits (Ad)

He Is Giving Away Bitcoin

January 24, 2024 | finance.yahoo.com

Soft Tissue Biologics Product Pipeline Report 2023: Reveals Key Development Stages, Industry Trends, Regions, and Companies

January 24, 2024 | finance.yahoo.com

Fill Finish Manufacturing Market Forecast Report - A US$ 17.165 Billion Market by 2030, Amplified by Rising Demand for Prefilled Syringes

December 15, 2023 | uk.investing.com

Y Biologics Inc (338840)

October 17, 2023 | reuters.com

Chinese EV startup WM Motor files for pre-restructuring

October 4, 2023 | finanznachrichten.de

EV Biologics Corporation: EV Biologics Updates on Funding and Sales

April 19, 2024 | Crypto Swap Profits (Ad)

He Is Giving Away Bitcoin

October 2, 2023 | finance.yahoo.com

EV Biologics Updates on Funding and Sales

August 16, 2023 | finance.yahoo.com

EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic

August 7, 2023 | finance.yahoo.com

EV Biologics Appoints Senior Investment Banker as Corporate Finance Director

August 3, 2023 | money.usnews.com

How the New EV Tax Credit Will Affect Your Auto Loan

August 2, 2023 | finanznachrichten.de

EV Biologics Corporation: EV Biologics Hires Senior Chief Financial Officer

August 2, 2023 | finance.yahoo.com

EV Biologics Hires Senior Chief Financial Officer

July 30, 2023 | news.yahoo.com

Toyota is planning a new EV with a 900-mile range and 10-minute charging time: ‘The holy grail of battery vehicles’

July 16, 2023 | usatoday.com

Are you a gas guzzler? The government might try to persuade you to switch to an EV

June 21, 2023 | usatoday.com

How reliable are public EV charging stations? Report shows many EV drivers have issues

May 27, 2023 | finance.yahoo.com

EV Biologics, Inc. (YECO)

May 17, 2023 | finanznachrichten.de

EV Biologics Corporation: EV Biologics Signs Exclusive Distribution Agreement for South America

May 15, 2023 | finance.yahoo.com

EV Biologics Signs Exclusive Distribution Agreement for South America

May 11, 2023 | benzinga.com

Best EV Penny Stocks

April 30, 2023 | washingtonpost.com

GM to scrap Chevy Bolt, its most popular and least expensive EV

March 19, 2023 | a.msn.com

Tesco EV charging network reaches 600 UK stores – and rapid chargers go live

February 21, 2023 | finanznachrichten.de

EV Biologics Corporation: EV Biologics Generates Mesenchymal Stem Cell Lines

February 21, 2023 | finance.yahoo.com

EV Biologics Generates Mesenchymal Stem Cell Lines

January 3, 2023 | finanznachrichten.de

EV Biologics Corporation: EV Biologics Updates on Excyte Subsidiary Funding

See More Headlines

Receive YECO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EV Biologics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Construction
Industry: Concrete, gypsum, & plaster products
Sub-Industry: N/A
Current Symbol: OTCMKTS:YECO
CUSIP: N/A
CIK: 1607741
Web: www.evbiologics.com
Phone: (518) 638-8192
Fax: N/A
Employees: 284
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 10,230,000
Free Float: 6,006,000
Market Cap: $6.16 million
Optionable: Not Optionable
Beta: -0.50

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Daniel S. McKinney (Age 62)
Founder, Chairman & CEO
Mr. Monte Fisher
Chief Financial Officer
Mr. William Bossung
Corporate Finance Director & Corporate Secretary

Key Competitors

View All Competitors

YECO Stock Analysis - Frequently Asked Questions

How have YECO shares performed in 2024?: EV Biologics' stock was trading at $1.00 at the beginning of 2024. Since then, YECO stock has decreased by 39.8% and is now trading at $0.6021.
View the best growth stocks for 2024 here.
Are investors shorting EV Biologics?: EV Biologics saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 100 shares, a decrease of 75.0% from the February 29th total of 400 shares. Based on an average daily trading volume, of 400 shares, the short-interest ratio is currently 0.3 days.
View EV Biologics' Short Interest.
How do I buy shares of EV Biologics?: Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:YECO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial